1 Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61:1–241.
2 Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784–789.
3 Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al.; Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372:392–397.
4 Choi J, Kim SG, Yoon H, Im JP, Kim JS, Kim WH, et al. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol 2014; 12:793–800.e1.
5 Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 2016; 150:1113–1124.e5.
6 Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of ran- domised controlled trials. BMJ 2014; 348:g3174.
7 Fuccio L, Zagari RM, Minardi ME, Bazzoli F. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007; 25:133–141.
8 Yoon SB, Park JM, Lim CH, Cho YK, Choi MG. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter 2014; 19:243–248.
9 Uemura N, Okamoto S. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer in Japan. Gastroenterol Clin North Am 2000; 29:819–827.
10 Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al.; China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291:187–194.
11 Bae SE, Jung HY, Kang J, Park YS, Baek S, Jung JH, et al. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm. Am J Gastroenterol 2014; 109:60–67.
12 Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, et al. Long-term effect of Helicobacter pylori eradication on the devel- opment of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 2012; 75:39–46.
13 Nakagawa S, Asaka M, Kato M, Nakamura T, Kato C, Fujioka T, et al. Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer. Aliment Pharmacol Ther 2006; 24:214–218.
14 Kwon YH, Heo J, Lee HS, Cho CM, Jeon SW. Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Aliment Pharmacol Ther 2014; 39:609–618.
15 Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, et al. The effect of eradicating Helicobacter pylori on the development of gastric
cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005; 100:1037–1042.
16 Kim YI, Choi IJ, Kook MC, Cho SJ, Lee JY, Kim CG, et al. The associ- ation between Helicobacter pylori status and incidence of metachro- nous gastric cancer after endoscopic resection of early gastric cancer. Helicobacter 2014; 19:194–201.
17 Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on pre- cancerous gastric lesions. Gut 2012; 61:812–818.
18 Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma
K. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol 2007; 42(Suppl 17):21–27.
19 Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 2005; 21:1121–1126.
20 Kato M, Nishida T, Yamamoto K, Hayashi S, Kitamura S, Yabuta T, et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a mul- ticentre retrospective cohort study by Osaka University ESD study group. Gut 2013; 62:1425–1432.
21 Yamamoto K, Kato M, Takahashi M, Haneda M, Shinada K, Nishida U, et al. Clinicopathological analysis of early-stage gastric can- cers detected after successful eradication of Helicobacter pylori. Helicobacter 2011; 16:210–216.
22 Hori K, Watari J, Yamasaki T, Kondo T, Toyoshima F, Sakurai J, et al. Morphological characteristics of early gastric neoplasms detected after Helicobacter pylori eradication. Dig Dis Sci 2016; 61:1641–1651.
23 Matsuo T, Ito M, Tatsugami M, Boda T, Takata S, Tanaka S, et al. Gastric cancer development after Helicobacter pylori eradication ther- apy: a new form of gastric neoplasia. Digestion 2012; 85:61–67.
24 Ito M, Tanaka S, Takata S, Oka S, Imagawa S, Ueda H, et al. Morphological changes in human gastric tumours after eradica- tion therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther 2005; 21:559–566.
25 Kitamura Y, Ito M, Matsuo T, Boda T, Oka S, Yoshihara M, et al. Characteristic epithelium with low-grade atypia appears on the sur- face of gastric cancer after successful Helicobacter pylori eradication therapy. Helicobacter 2014; 19:289–295.
26 Kobayashi M, Hashimoto S, Nishikura K, Mizuno K, Takeuchi M, Sato Y, et al. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradica- tion. J Gastroenterol 2013; 48:1332–1342.
27 Saka A, Yagi K, Nimura S. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication ther- apy. Gastric Cancer 2016; 19:524–530.
28 Kimura K, Takemoto T. An endoscopic recognition of the atrophic bor- der and its significance in chronic gastritis. Endoscopy 1969; 3:87–97.
29 Sugimoto M, Ban H, Ichikawa H, Sahara S, Otsuka T, Inatomi O, et al. Efficacy of the Kyoto classification of gastritis in identifying patients at high risk for gastric cancer. Intern Med 2017; 56:579–586.
30 Japanese Gastric Cancer Association. Japanese classification of gas- tric carcinoma: 3rd English edition. Gastric Cancer 2011; 14:101–112.
31 Japanese Gastric Cancer Association. Japanese gastric cancer treat- ment guidelines 2014 (ver. 4). Gastric Cancer 2017; 20:1–19
32 Nishikura K, Watanabe H, Ajioka Y. Effect of Helicobacter pylori infection on carcinogenesis and development of gastric adenocar- cinoma on differentiated type. Bacterial Adherence & Biofilm 2001; 15:133–138.
33 Asada K, Nakajima T, Shimazu T, Yamamichi N, Maekita T, Yokoi C, et al. Demonstration of the usefulness of epigenetic cancer risk predic- tion by a multicentre prospective cohort study. Gut 2015; 64:388–396.
34 Cho CJ, Ahn JY, Jung HY, Jung K, Oh HY, Na HK, et al. The incidence and locational predilection of metachronous tumors after endoscopic resection of high-grade dysplasia and early gastric cancer. Surg Endosc 2017; 31:389–397.
35 Moon HS, Yun GY, Kim JS, Eun HS, Kang SH, Sung JK, et al. Risk factors for metachronous gastric carcinoma development after endo- scopic resection of gastric dysplasia: Retrospective, single-center study. World J Gastroenterol 2017; 23:4407–4415.